Results 21 to 30 of about 65,591 (261)

Frequency of Her2/Neu Immuno Histochemical Expression in Bladder Urothelial Carcinoma: A Study At CMH Quetta

open access: yesProceedings, 2022
Introduction: The staining pattern of HER2/Neu expression in urothelial bladder cancer has been established for more than a decade, and literature review of the past reveals a dismal prognosis in Her2/Neu expressed invasive urothelial carcinoma. Aims &
Javeria Faridi   +5 more
doaj   +1 more source

Small bowel obstruction secondary to metastatic urothelial bladder cancer

open access: yesSAGE Open Medical Case Reports, 2023
Small bowel obstruction secondary to primary cancer, such as carcinoid and adenocarcinoma, is not unusual. Less frequently, hematological metastasis from breast, lung, and melanoma can occur.
Tarik Wasfie   +4 more
doaj   +1 more source

Testicular metastasis from urothelial carcinoma of the bladder

open access: yesIJU Case Reports, 2022
Introduction Reports of urothelial carcinoma with testicular metastasis are limited and the etiology and prognosis remain unclear. We report a rare case of testicular metastasis derived from bladder urothelial carcinoma.
Eri Fukagawa   +4 more
doaj   +1 more source

Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker. [PDF]

open access: yes, 2018
Though bladder urothelial carcinoma is the most common form of bladder cancer, advances in its diagnosis and treatment have been modest in the past few decades.
Li, Wei Tse   +4 more
core   +2 more sources

Urothelial bladder carcinoma metastasizing to the eye: a systematic review and case report [PDF]

open access: yes, 2019
The eye is a rare site for disseminated malignancies; nevertheless, several tumors may metastasize to ocular structures. Few cases of urothelial and bladder cancer with eye involvement have been described in the literature thus far.
Brunelli, Matteo   +12 more
core   +1 more source

Urothelial carcinoma of the urinary bladder in a 12-year-old girl: A case report with immunohistological analysis and a review of the literature

open access: yesUrology Case Reports, 2018
Urothelial carcinoma of the bladder in childhood is extremely rare. We report on a 12-year-old girl with urothelial carcinoma of the bladder who presented with gross hematuria.
Taiki Kato   +9 more
doaj   +1 more source

Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery [PDF]

open access: yes, 2011
Objective: The aim of this study was to externally validate the prognostic value of concomitant urothelial carcinoma in situ (CIS) in radical cystectomy (RC) specimens using a large international cohort of bladder cancer patients. Methods: The records of
Colin P. Dinney   +26 more
core   +1 more source

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors [PDF]

open access: yes, 2018
To compare long-term overall survival (OS) in patients with G1 and G2 grade Ta bladder cancer after transurethral resection of bladder tumors (TURBTs).
Balan, Daniel   +16 more
core   +2 more sources

Giant Cell Urothelial Carcinoma of Bladder

open access: yesCase Reports in Urology, 2021
Giant cell urothelial carcinoma is a rare variant of bladder cancer recognized by the current World Health Organization classification of urologic tumours. It is an aggressive tumour with a poor prognosis that usually presents at an advanced stage. It is characterized histologically by pleomorphic giant cells. We discuss a case of giant cell urothelial
Harshima Disvini Wijesinghe   +1 more
openaire   +3 more sources

A rare case of plasmacytoid urothelial carcinoma of bladder: Diagnostic dilemmas and clinical implications

open access: yesIndian Journal of Urology, 2011
Plasmacytoid urothelial carcinoma is an uncommon and aggressive variant of urothelial carcinoma associated with late presentation and poor prognosis. We discuss here the first reported case from India of a 54-year-old male who presented with hematuria ...
Khaliqur Rahman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy